Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04439084 · ClinicalTrials.gov registry record
COVID-19 in Patients With Chronic Liver Diseases
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 1,025
- Enrollment target
NCT04439084: Completed study, sponsored by Stanford University.
NCT04439084 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 1,025 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04439084 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 1,025 participants
- Enrollment target
Study Summary
This study seeks to determine how COVID-19 affects the clinical outcome of patients with chronic liver disease, and whether the clinical course of COVID-19 is influenced by underlying chronic liver disease.
Interventions
- OTHER Prospective Chart Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,025 participants |
| Start Date | 2020-03-06 |
| Est. Completion | 2021-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04439084
The ClinicalTrials.gov registry entry for NCT04439084 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,025 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prospective Chart Review is the first listed.
NCT04439084 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04439084 about?
NCT04439084 is a clinical study titled "COVID-19 in Patients With Chronic Liver Diseases". This study seeks to determine how COVID-19 affects the clinical outcome of patients with chronic liver disease, and whether the clinical course of COVID-19 is influenced by underlying chronic liver disease.
What is the current status of trial NCT04439084?
This trial is currently completed. The enrollment target is 1,025 participants. The study started on 2020-03-06. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT04439084?
The interventions under investigation include: Prospective Chart Review (OTHER).
Who is sponsoring clinical trial NCT04439084?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.